These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30883224)

  • 1. Recommended Heart Failure Medications and Adverse Drug Reactions in Women.
    Bots SH; den Ruijter HM
    Circulation; 2019 Mar; 139(12):1469-1471. PubMed ID: 30883224
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature.
    Bots SH; Groepenhoff F; Eikendal ALM; Tannenbaum C; Rochon PA; Regitz-Zagrosek V; Miller VM; Day D; Asselbergs FW; den Ruijter HM
    JACC Heart Fail; 2019 Mar; 7(3):258-266. PubMed ID: 30819382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failure.
    Hennekens CH; Kowalczykowski M; Hollar D
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):149-52. PubMed ID: 16891293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of the RALE study. Hyperkalemia following spironolactone treatment].
    Erdmann E
    Internist (Berl); 2005 Apr; 46(4):466, 468. PubMed ID: 15723149
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperkalemia Associated with Renin-Angiotensin-Aldosterone System Inhibition in Patients with Heart Failure; Underexplored and Overrated?
    Koratala A; Aboud H; Kazory A
    Nephron; 2018; 138(3):220-221. PubMed ID: 29176327
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure.
    Watz R; Ekstrand AB; Engelbrektson V; Beermann B
    Eur J Clin Pharmacol; 2005 May; 61(3):209-14. PubMed ID: 15761755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs?
    Parwani P; Ryan J
    Circ Heart Fail; 2012 Nov; 5(6):819. PubMed ID: 23170021
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of spironolactone in heart failure patients receiving angiotensin-converting enzyme inhibitors and beta-blockers.
    Ahmed A
    J Am Coll Cardiol; 2003 May; 41(10):1851-2. PubMed ID: 12767683
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological treatment of chronic heart failure.
    Adorisio R; De Luca L; Rossi J; Gheorghiade M
    Heart Fail Rev; 2006 Jun; 11(2):109-23. PubMed ID: 16937030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiotensin receptor blockers in heart failure. CHARM Study].
    Kochsiek K
    Internist (Berl); 2004 Sep; 45(9):1063-7. PubMed ID: 15309315
    [No Abstract]   [Full Text] [Related]  

  • 11. What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Tajik AA; Dickstein K
    Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799
    [No Abstract]   [Full Text] [Related]  

  • 12. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug treatment for chronic heart failure with reduced ejection fraction].
    Rickenbacher P
    Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in pharmacotherapy of hospitalized patients with heart failure for 16 years].
    Savina NM; Aleksandrova AIu; Sidorenko BA
    Kardiologiia; 2010; 50(6):53. PubMed ID: 20659028
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacologic treatment of heart failure in the elderly].
    Erdmann E
    Dtsch Med Wochenschr; 2013 Apr; 138(14):700-2. PubMed ID: 23533033
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapies for heart failure: a report from the Heart Failure Congress 2007.
    Rabasseda X
    Timely Top Med Cardiovasc Dis; 2007 Jul; 11():E16. PubMed ID: 18297144
    [No Abstract]   [Full Text] [Related]  

  • 17. Medication adherence in patients with heart failure and a depressed ejection fraction attending cardiology clinics.
    Crespo Leiro MG; Murga N; Matalí A; López-Sendón JL
    Rev Esp Cardiol; 2009 Apr; 62(4):454-5. PubMed ID: 19401134
    [No Abstract]   [Full Text] [Related]  

  • 18. MY APPROACH to the patient with heart failure and improved ejection fraction
    Cohn JN
    Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: what we know and current controversies.
    Moser DK; Biddle MJ
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):423-37, vii-viii. PubMed ID: 14717387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.